# Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes

> **NCT01082198** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Maria Sklodowska-Curie National Research Institute of Oncology** · enrollment: 22 (estimated)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **BIOLOGICAL:** HLA-A1-binding MAGE-1/MAGE-3 multipeptide-pulsed autologous dendritic cell vaccine
- **BIOLOGICAL:** HLA-A2-binding TYR/MART-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine
- **BIOLOGICAL:** autologous melanoma lysate-pulsed autologous dendritic cell vaccine
- **BIOLOGICAL:** autologous melanoma lysate/KLH-pulsed autologous dendritic cell vaccine
- **BIOLOGICAL:** dendritic cell-idiotype-keyhole limpet hemocyanin vaccine
- **OTHER:** flow cytometry
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT01082198
- **Lead sponsor:** Maria Sklodowska-Curie National Research Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-10
- **Primary completion:** 2010-04
- **Final completion:** —
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082198, "Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01082198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*